Collaboration for AIDS Vaccine Discovery (CAVD)

United States of America (USA)

1 May 2019 - 30 April 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Collaboration for AIDS Vaccine Discovery (CAVD) published between 1 May 2019 - 30 April 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
1 0.24

Outputs by subject (Share)

Subject Count Share
Chemistry 1 0.24
Life Sciences 1 0.24
Physical Sciences 1 0.24

Top articles by Altmetric score in current window

1 May 2019 - 30 April 2020

International vs. domestic collaboration by Share

  • 24.04% Domestic
  • 75.96% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (3 total)

  • Collaboration for AIDS Vaccine Discovery (CAVD), United States of America (USA)
  • Domestic institution
  1. Cornell University, United States of America (USA) (0.28)
    0.24
    0.04
  2. New England Biolabs, Inc. (NEB), United States of America (USA) (0.26)
    0.24
    0.01
  3. Amgen Inc., United States of America (USA) (0.26)
    0.24
    0.01

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Collaboration for AIDS Vaccine Discovery (CAVD) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs